n-(9h-(2,7-dimethylfluoren-9-ylmethoxy)carbonyl)leucine has been researched along with Pulmonary Hypertension in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burch, RM; Cameron, DE; Cho, PW; Gillinov, AM; Winkelstein, JA; Zehr, KJ | 1 |
1 other study(ies) available for n-(9h-(2,7-dimethylfluoren-9-ylmethoxy)carbonyl)leucine and Pulmonary Hypertension
Article | Year |
---|---|
Neutrophil activation mediates protamine-induced pulmonary hypertension.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens, CD; CD18 Antigens; Hemodynamics; Hypertension, Pulmonary; Leucine; Neutrophils; Peroxidase; Protamines; Swine | 1993 |